Infant Bacterial Therapeutics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Infant Bacterial Therapeutics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 72.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
We Think Infant Bacterial Therapeutics (STO:IBT B) Can Afford To Drive Business Growth
Aug 02
Infant Bacterial Therapeutics AB (publ)'s (STO:IBT B) CEO Compensation Is Looking A Bit Stretched At The Moment
May 02Infant Bacterial Therapeutics (STO:IBT B) Is In A Good Position To Deliver On Growth Plans
Apr 03Here's Why We're Not Too Worried About Infant Bacterial Therapeutics' (STO:IBT B) Cash Burn Situation
Sep 16We Think Infant Bacterial Therapeutics (STO:IBT B) Can Afford To Drive Business Growth
May 11We're Not Very Worried About Infant Bacterial Therapeutics' (STO:IBT B) Cash Burn Rate
Sep 23We're Hopeful That Infant Bacterial Therapeutics (STO:IBT B) Will Use Its Cash Wisely
Apr 07We Think Infant Bacterial Therapeutics (STO:IBT B) Can Afford To Drive Business Growth
Dec 15We Think Infant Bacterial Therapeutics (STO:IBT B) Can Afford To Drive Business Growth
Aug 25We're Not Very Worried About Infant Bacterial Therapeutics' (STO:IBT B) Cash Burn Rate
May 06Anthon Jahreskog Just Bought A Sprinkling of Shares In Infant Bacterial Therapeutics AB (publ) (STO:IBT B)
Feb 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Infant Bacterial Therapeutics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 0 | -144 | -134 | -134 | N/A |
| 6/30/2024 | 0 | -142 | -121 | -121 | N/A |
| 3/31/2024 | 0 | -128 | -97 | -97 | N/A |
| 12/31/2023 | 0 | -123 | -101 | -101 | N/A |
| 9/30/2023 | 0 | -122 | -95 | -95 | N/A |
| 6/30/2023 | 0 | -99 | -88 | -88 | N/A |
| 3/31/2023 | 0 | -69 | -103 | -103 | N/A |
| 12/31/2022 | 0 | -65 | -86 | -86 | N/A |
| 9/30/2022 | 0 | -42 | -73 | -73 | N/A |
| 6/30/2022 | 0 | -34 | -76 | -76 | N/A |
| 3/31/2022 | N/A | -65 | -57 | -57 | N/A |
| 12/31/2021 | N/A | -45 | -56 | -56 | N/A |
| 9/30/2021 | N/A | -55 | -76 | -76 | N/A |
| 6/30/2021 | N/A | -74 | -57 | -57 | N/A |
| 3/31/2021 | N/A | -73 | -60 | -60 | N/A |
| 12/31/2020 | N/A | -72 | -58 | -58 | N/A |
| 9/30/2020 | N/A | -73 | -37 | -37 | N/A |
| 6/30/2020 | N/A | -65 | -65 | -65 | N/A |
| 3/31/2020 | N/A | -44 | -54 | -54 | N/A |
| 12/31/2019 | N/A | -46 | -51 | -51 | N/A |
| 9/30/2019 | N/A | -43 | -67 | -67 | N/A |
| 6/30/2019 | N/A | -40 | -42 | -42 | N/A |
| 3/31/2019 | N/A | -32 | -45 | -45 | N/A |
| 12/31/2018 | N/A | -41 | -47 | -47 | N/A |
| 9/30/2018 | N/A | -26 | -30 | -30 | N/A |
| 6/30/2018 | N/A | -22 | N/A | -30 | N/A |
| 3/31/2018 | 0 | -37 | N/A | -34 | N/A |
| 12/31/2017 | 0 | -36 | N/A | -35 | N/A |
| 9/30/2017 | 0 | -41 | N/A | -42 | N/A |
| 6/30/2017 | 0 | -44 | N/A | -41 | N/A |
| 3/31/2017 | 0 | -42 | N/A | -42 | N/A |
| 12/31/2016 | 0 | -38 | N/A | -40 | N/A |
| 9/30/2016 | 0 | -19 | N/A | -34 | N/A |
| 6/30/2016 | N/A | -7 | N/A | -33 | N/A |
| 3/31/2016 | N/A | 0 | N/A | -23 | N/A |
| 12/31/2015 | N/A | 0 | N/A | -17 | N/A |
| 12/31/2014 | N/A | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if IBT B's forecast earnings growth is above the savings rate (1.2%).
Earnings vs Market: Insufficient data to determine if IBT B's earnings are forecast to grow faster than the Swedish market
High Growth Earnings: Insufficient data to determine if IBT B's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if IBT B's revenue is forecast to grow faster than the Swedish market.
High Growth Revenue: Insufficient data to determine if IBT B's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IBT B's Return on Equity is forecast to be high in 3 years time